Dr. Merli expects the majority of physicians will take a wait-and-see approach to the new anticoagulants.
“I think 20 percent will adopt the drug early,” he says. “Then there’s that big group in the middle, 60 percent, that will wait and see and they’ll start using it. And then there’s that end group of 20 percent that will never use the drug.” TH
Thomas R. Collins is a freelance writer based in Florida.